Clinical Trials Directory

Trials / Completed

CompletedNCT02589405

Benzac 5% Gel in Combination With Cosmetic Products in Acne Vulgaris

Benzaknen® 5% Gel in Combination With Dermotivin® Soft Liquid Soap and Non-comedogenic Cetaphil® Dermacontrol Moisturizer SPF30 in the Treatment of Mild-to-moderate Acne Vulgaris

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Galderma R&D · Industry
Sex
All
Age
12 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate a complete acne regimen consisting of a medication (Benzaknen® 5% Gel), and 2 cosmetic products Dermotivin® Soft Liquid soap and Cetaphil® Dermacontrol Moisturizer SPF30 in patients with acne.

Detailed description

The main objective of this study is to evaluate subject satisfaction with the treatment regimen comprising Benzaknen® 5% Gel in association with 2 cosmetic products including a foam soap, Dermotivin® Soft Liquid soap, and a non comedogenic moisturizer, Cetaphil® Dermacontrol Moisturizer SPF30, in patients with mild to moderate acne, after 12 weeks of treatment.

Conditions

Interventions

TypeNameDescription
DRUGBenzoyl Peroxide
OTHERDermotivin® Soft Liquid cleanser
OTHERCetaphil® Dermacontrol Moisturizer SPF30

Timeline

Start date
2015-08-01
Primary completion
2016-01-01
Completion
2016-01-01
First posted
2015-10-28
Last updated
2021-02-18
Results posted
2019-02-11

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02589405. Inclusion in this directory is not an endorsement.